Skip 
Navigation Link
Health Insurance
Resources
Basic InformationLatest News
Most People Not Bargain Hunters When It Comes to Health CareSenate Says No to 'Skinny' Obamacare Repeal BillNew Alcohol Screening, Brief Intervention Manual DevelopedSenate Rejects Repeal of Obamacare Without ReplacementSenate Prepares for Health Care VoteInsured, But Still Barred From Top-Tier Cancer CentersAs Efforts to Repeal Obamacare Fail, Future of Health Care Reform in LimboRevised Senate Bill Would Allow Bare-Bones Health PlansAmerican Adults Without Health Insurance Rises by Two MillionLack of Health Insurance Can Shorten Lives: StudySenate GOP Leaders Delay Vote on Health Reform BillSome Republicans Voice Concerns About Senate Replacement for ObamacareSenate Republicans Reveal Their Replacement for ObamacareHealth Insurers Recruiting Former Pharma Reps to Cut CostsLeading Medical Groups Mobilize Against Obamacare RepealUncertainty for Obamacare Plans as Filing Deadline Approaches4 in 10 Job-Based Health Plans in U.S. Are Now 'High-Deductible'High-Risk Pools May Represent Step Back for U.S. Health CareCBO: 23 Million Would Lose Health Insurance Under House Health Care BillObamacare a Win-Win for Poorer Adults: StudyCDC: Slowing of Decline in Number of Uninsured AdultsPeople With Pre-Existing Health Issues Fear Repeal-and-Replace BillIncreases in Rates of Insured Don't Harm Continuously InsuredGOP Health Reform Push Faces Uncertain Future in the SenateHouse OKs Republican Health Care BillAmericans Uneasy With Push to Repeal Obamacare: HealthDay/Harris PollHouse to Vote Thursday on Amended Bill to Repeal and Replace ObamacareHouse Delays Vote on Obamacare OverhaulSingle-Payer Health System Bill Moves Forward in CaliforniaCrossroads for ObamacareTrump Rolls Out First Set of Obamacare FixesWhite House, GOP Lawmakers Revisit Health Care BillTV Ads for ACA Enrollment Linked to Decline in Uninsured RatesHealth Insurance a Key to IVF Success, Researchers SayHouse Republican Leaders Pull Bill Aimed at Repealing 'Obamacare'Analysis: Millions Would Lose Health Coverage Under GOP OverhaulACA's Medicaid Expansion May Pose Challenges to Timely CareObamacare's Medicaid Expansion Cut Medical Bill Worries, Study FindsRepublicans Introduce Affordable Care Act ReplacementPatient Organizations Offer Advice on Reforming ObamacareOverall, 8.8 Percent of U.S. Population Uninsured in 2016Doctors Handled Influx of Obamacare Patients: StudyCMS Rule Set to Stabilize Small Health Insurance MarketsThe Short- and Long-Term Prognosis for ObamacareTrump Administration Rolls Out New Obamacare RulesWhat's Next for the Obamacare Insurance Exchanges?Jan. 31 Is Next Deadline to Enroll for ObamacareMajority of Primary Care Docs Oppose Repeal of Obamacare: SurveyObamacare Boosted Coverage for the Chronically Ill, Study Finds2 GOP Senators Unveil Obamacare Alternative
Questions and AnswersLinksBook Reviews
Related Topics

Health Policy & Advocacy
Healthcare
Workplace and Career Issues

Health Insurers Recruiting Former Pharma Reps to Cut Costs


HealthDay News
Updated: Jun 16th 2017

new article illustration

FRIDAY, June 16, 2017 (HealthDay News) -- Health insurers are recruiting former pharmaceutical company representatives to educate doctors and help save money on prescription medications, according to a report published June 8 in Kaiser Health News.

Noting that costs for prescription drugs have been rising faster than those for any other health segment, health plans and others paying those costs are trying to address the increases.

Capital District Physicians' Health Plan (CDPHP), an Albany, N.Y., insurer, is hiring former pharma representatives and staffing a sales force to develop cost-effective medicine. They have been able to address rising costs of prescription medications, such as Glumetza (metformin hydrochloride), manufactured by Valeant Pharmaceuticals, which reached a price of $81,270 per year. When CDPHP doctors were informed of the price, most of the 60 plan members who were taking Glumetza were switched to the generic alternative, saving $5 million in one year.

"Insurers are taking matters into their own hands," said Lea Prevel Katsanis, a marketing professor at Concordia University in Montreal, according to the article. "They're saying, 'We can't really rely on drug companies to talk to doctors about what's cost-efficient.'"

More Information